ArticleClinical and translational radiation oncology2025
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer.
Article in Clinical and translational radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Evaluation of a quasi-automatic treatment planning workflow for head-and-neck cancer in radiotherapy.Physics and imaging in radiation oncology · 2026Article
- Prospective blinded clinical evaluation of a fully automated workflow for prostate radiotherapy.Physics and imaging in radiation oncology · 2026Article
- AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.Frontiers in oncology · 2026Review
- Isotoxic stereotactic reirradiation for recurrent pelvic cancers.Physics and imaging in radiation oncology · 2026Article
- Artificial Intelligence Across the Prostate Cancer Pathway: Screening, Imaging, Pathology, and Biomarkers.Cureus · 2025Review
- AI in Radiation Oncology: A Comprehensive Review of Current Applications and Future Directions.Cureus · 2025Review
- The risks of telehealth in radiation oncology: challenges and mitigation strategies.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The integration of artificial intelligence into radiotherapy planning for prostate cancer has demonstrated promise in enhancing efficiency and consistency. In this study, we assess the clinical feasibility of a fully automated machine learning (ML)-based "one-click" workflow that combines ML-based segmentation and treatment planning. The proposed workflow was designed to create a clinically acceptable radiotherapy plan within the inter-observer variation of conventional plans. Methods: We evaluated the fully-automated workflow on five low-risk prostate cancer patients treated with external beam radiotherapy and compared the results with conventional optimized and inverse planned radiotherapy plans based on the contours of six different experienced radiation oncologists. Both qualitative and quantitative metrics were analyzed. Additionally, we evaluated the dose distribution of the ML-based and conventional radiation treatment plans on the different segmentations (manual vs. manual and manual vs. automation). Results: The automatic deep-learning segmentation of the target volume revealed a close agreement between the deep-learning based and expert contours referring to Dice Similarity- and Hausdorff index. However, the deep-learning based CTVs had a significantly smaller volume than the expert CTVs (47.1 cm3 vs. 62.6 cm Conclusion: Our study indicates that the tested fully automated ML-based workflow is clinically feasible and leads to comparable results to conventional radiation treatment plans. This represents a promising step towards efficient and standardized prostate cancer treatment. Nevertheless, in the evaluated cohort, auto segmentation was associated with smaller target volumes compared to manual contours, highlighting the necessity of improving segmentation models and prospective testing of automation in radiation therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.